This article is intended for primary care clinicians, obstetricians, and other specialists who care for pregnant women.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material activity, Medscape Education Clinical Briefs has been reviewed and is acceptable for up to 260 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2012. Term of approval is for 1 year from this date. Each Clinical Brief is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of each Clinical Brief. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: Total credit is subject to change based on topic selection and article length.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
AAFP Accreditation Questions
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 4/12/2013
Valid for credit through: 4/12/2014
processing....
The role of vitamin D in pregnancy is controversial, and an editorial by Steer, which accompanies the current article, describes the conflicting evidence and recommendations regarding vitamin D supplementation during pregnancy. First, according to current standards from the US National Institutes of Health, nearly half of pregnant white women might be considered to be vitamin D deficient. The rate of vitamin D deficiency is even higher among pregnant women of color. This had led national societies in England and Canada to recommend the consideration of routine vitamin D supplementation among pregnant women at doses of 400 to 2000 IU daily.
However, other important health agencies recommend against routine testing of 25-hydroxyvitamin D (25[OH]D) levels during pregnancy or routine vitamin D supplementation. Some research has found no association between maternal 25(OH)D levels and outcomes such as recurrent preterm birth, diabetes, or mode of delivery. A systematic review found insufficient evidence regarding the potential benefits and harms of vitamin D supplements during pregnancy to make any meaningful practice recommendations.
The current study by Lawlor and colleagues addresses an important aspect of the controversy of vitamin D in pregnancy: the effect of maternal 25(OH)D levels on the bone density of offspring.
A large, prospective cohort study has found no association between vitamin-D levels of mothers in pregnancy and the subsequent bone-mineral content of their children at age 9 years. The findings should lead to a reexamination of UK guidelines for vitamin-D supplementation in pregnancy, say the authors.
"We believe...that there is no strong evidence that pregnant women should receive vitamin-D supplementation to prevent low bone-mineral content in their offspring," say Debbie A Lawlor, PhD, from the University of Bristol, United Kingdom, and colleagues in their paper published online March 19, 2013, in the Lancet. However, they caution: "We cannot comment on other possible effects of vitamin D in pregnant women."
In an accompanying comment, Philip J Steer, MD, from Imperial College London, United Kingdom, notes that current UK (National Institute for Health and Clinical Excellence [NICE]) guidelines recommend that all pregnant and breast-feeding women should take a 10-µg vitamin-D supplement every day, despite prior inconsistent results of studies examining vitamin D and various outcomes in pregnancy. Similarly, the Canadian Paediatric Society recommends administering 2000 IU of vitamin D daily to pregnant and lactating women.
But in contrast, the American College of Obstetricians and Gynecologists concluded in July 2011 that "there is insufficient evidence to support a recommendation for screening all pregnant women for vitamin-D deficiency," he notes. The Americans further suggested that "vitamin-D supplementation during pregnancy beyond that contained in a prenatal vitamin should await the completion of ongoing randomized clinical trials," he observes.
Optimum Approach Unclear; Wait for Long-Term Trials
Given the new findings of Dr. Lawlor and colleagues, Dr. Steer says: "The safest approach is probably routinely to supplement pregnant women at greatest risk, as defined by the NICE guidelines: women of south Asian, black African, black Caribbean, or Middle Eastern origin; women who have limited exposure to sunlight (eg, those who are predominantly housebound or are generally fully covered when outdoors); women who eat a diet particularly low in vitamin D (eg, no oily fish, eggs, meat, or vitamin D-fortified margarine or breakfast cereal); and women with a body mass index higher than 30 kg/m² before pregnancy."
"For other women, the optimum approach is unclear, and long-term randomized trials of supplementation are justified," he stresses.
Largest Observational Study to Look at Vitamin D in Pregnancy
Dr. Lawlor's research is the largest-ever observational study of the effects of a mother's vitamin-D levels in pregnancy on her children’s bone health. Very low levels of vitamin D are known to cause rickets, and suboptimal levels can still cause thinning of the bones (osteomalacia), she and her colleagues note.
They assessed vitamin-D levels in 3960 pregnant women, mostly of white European origin, recording data from all 3 trimesters. When their children had reached an average age of 9 years and 11 months, their bone-mineral content — total body less head (TBLH; n=3960) and spinal (n=3196) was assessed using dual-energy X-ray absorptiometry.
Of the women, 2644 (67%) had sufficient, 1096 (28%) insufficient, and 220 (6%) deficient vitamin D, as measured by 25(OH)D concentrations, but TBLH and spinal bone-mineral content did not differ between offspring of mothers in the lower 2 groups vs sufficient 25(OH)D concentration.
No associations with offspring bone-mineral content were found for any trimester, including the third trimester, which is thought to be most relevant (TBLH bone-mineral content confounder-adjusted mean difference –0.03 g per 10.0 nmol/L; spinal bone-mineral content 0.04 g per 10.0 nmol/L).
In an interview with Lancet TV, Dr. Lawlor said this is a cohort study, "and you worry that what you are seeing is explained by confounding. We did a lot of sensitivity analysis, trying to unpick whether somehow we might have gotten [it] wrong, and we absolutely couldn't find anything."
'Normal' Vitamin-D Levels in Pregnancy Not Known
In his comment, Dr. Steer notes that an extensive review published this year concluded that long-term safety data on vitamin-D supplementation "remain limited," and other recent reports suggest "no link between maternal 25 (OH)D concentrations and important pregnancy outcomes such as recurrent preterm birth, diabetes, or mode of delivery." In addition, a 2012 review surmised that the evidence for vitamin-D supplementation in pregnancy was "too limited to draw any conclusions on usefulness and safety and...further rigorous randomized trials are required."
He adds that "a particular difficulty" in deciding who should be supplemented is "the paucity of studies to define the normal range of 25(OH)D...during pregnancy." Dr. Lawlor agreed: "In pregnant women, it's not really clear what a normal level [of vitamin D] should be; when you are pregnant, your whole physiology changes. The evidence for what is normal in pregnancy is not fully understood."
Dr. Steer goes on to explain, however, that black and Asian women routinely have lower concentrations of 25(OH)D, and notes that in published reports about cases of rickets from Canada and the United Kingdom, the majority of affected children are nonwhite. In the Canadian report, 92% of those with rickets had dark skin, and only 1 out of 74 infants with rickets in the UK study was of white European origin (62% were Asian).
Hence his recommendation that women with dark skin and others who might be vitamin-D deficient due to diet or other reasons probably should still routinely receive vitamin-D supplements in pregnancy.
Dr. Lawlor and colleagues as well as Dr. Steer have disclosed no relevant financial relationships.
Lancet. Published online March 19, 2013. Abstract